APA (7th ed.) Citation

A, M., E, Z., E, C., D, C., F, U., A, F., & L, L. (2025). Innovative Drug Development Approach to Address the Transition to Low Global Warming Potential Propellant Using Hydrofluoroalkane-152a, for Triple Combination Pressurized Metered-Dose Inhaler Products Targeting Small Airways. AAPS PharmSciTech, 26(3), 72. https://doi.org/10.1208/s12249-025-03057-z

Chicago Style (17th ed.) Citation

A, Matturro, Zambelli E, Cuoghi E, Copelli D, Usberti F, Fioni A, and Labadini L. "Innovative Drug Development Approach to Address the Transition to Low Global Warming Potential Propellant Using Hydrofluoroalkane-152a, for Triple Combination Pressurized Metered-Dose Inhaler Products Targeting Small Airways." AAPS PharmSciTech 26, no. 3 (2025): 72. https://doi.org/10.1208/s12249-025-03057-z.

MLA (9th ed.) Citation

A, Matturro, et al. "Innovative Drug Development Approach to Address the Transition to Low Global Warming Potential Propellant Using Hydrofluoroalkane-152a, for Triple Combination Pressurized Metered-Dose Inhaler Products Targeting Small Airways." AAPS PharmSciTech, vol. 26, no. 3, 2025, p. 72, https://doi.org/10.1208/s12249-025-03057-z.